Valproate Toxicity: Risk-Screening Strategies

Abstract

Get full access to this article

View all access options for this article.

References

Willmore LJ , Wilder BJ , Bruni J. , et al: Effect of valproic acid on hepatic function. Neurology 1978;28:961-964.

Powell-Jackson PR , Tredger JM , Williams R. : Hepatotoxicity to sodium valproate: A review . Gut 1984;25:673-681.

Sussman NM , McLain LW : A direct hepatotoxic effect of valproic acid. JAMA 1979;242:1173-1174.

Suchy FJ , Balistreri WF , Buchino JJ , et al: Acute hepatic failure associated with the use of sodium valproate . N Engl J Med 1979;300:962-966.

Gerber N. , Dickinson G. , Harland RC , et al: Reye-like syndrome associated with valproic acid therapy. J Pediatr 1979;95:142-144.

Dreifuss FE , Langer DH , Moline KA , et al: Valproic acid hepatic fatalities. II. US experience since 1984 . Neurology 1989;39:201-207.

Scheffner D. , Konig S. , Rauterberg-Ruland I. , et al: Fatal liver failure in 16 children with valproate therapy. Epilepsia 1988;29:530-542.

Zimmerman HJ , Ishak KG : Valproate-induced hepatic injury: Analysis of 23 fatal cases. Hepatology 1982 ;2:591-597.

Dreifuss FE , Santilli N. , Langer DH , et al: Valproic acid hepatic fatalities: A retrospective review. Neurology 1987 ;37:379-385.

10.

Zarfani ES , Berthelot P. : Sodium valproate in the induction of unusual hepatotoxicity. Hepatology 1982;2:648-649.

11.

Van Egmond H. , Degomme P. , de Simpel H. , et al: A suspected case of late-onset sodium valproate-induced hepatic failure. Neuropediatrics 1987;18:96-98.

12.

Kuhara T. , Inoue Y. , Matsumoto M. , et al: Markedly increased ω-oxidation of valproate in fulminant hepatic failure. Epilepsia 1990;31:214-217.

13.

Sackellares JC , Lee SI , Dreifuss FE : Stupor following administration of valproic acid to patients receiving other antiepileptic drugs. Epilepsia 1979;20:697-703.

14.

Zaccara G. , Paganini M. , Campostrini R. , et al: Hyperammonemia and valproate-induced alterations of the state of consciousness. A report of eight cases. Eur Neurol 1984;23:104-112.

15.

Coulter DL , Allen RJ : Hyperammonemia with valproic acid therapy. J Pediatr 1981;99:317-319.

16.

Warter JM , Marescaux CH , Rumbach L. , et al: Role of hyperammonemia in stuporous states induced by sodium valproate. Rev Neurol 1983;139:753-757.

17.

Mortensen PB , Hansen HE , Pedersen B. , et al: Acute valproate intoxication: Biochemical investigations and hemodialysis treatment. Int J Clin Pharmacol Ther Toxicol 1983;21:64-68.

18.

Sills JA , Jones RHT , Taylor WH : Valproate, hyperammonemia, and hyperglycinemia. Lancet 1980;2:260-261.

19.

Coude FX , Grimer G. , Pelet A. , Benoit Y: Action of the antiepileptic drug, valproic acid, on fatty acid oxidation in isolated rat hepatocytes. Biochem Biophys Res Commun 1983 ;115:730-736.

20.

Thurston JH , Carroll JE , Norris BJ , et al: Acute in vivo and in vitro inhibition of palmitic acid and pyruvate oxidation by valproate and valproyl-coenzyme A in livers of infant mice. Ann Neurol 1983 ;14:384-385.

21.

Becker CM , Harris RA : Influence of valproic acid on hepatic carbohydrate and lipid metabolism . Arch Biochem Biophys 1983;223:381-392.

22.

Roe CR , Bohan TP : L-Carnitine therapy in propionic acidaemia. Lancet 1982;1:1411-1412.

23.

Steiman GS , Woerpel RW , Sherard ES : Treatment of accidental sodium valproate overdose with an opiate antagonist . Ann Neurol 1979;6:274.

24.

Koskiniemi M. , Hakamies L. : Valproic acid and coma. Neurology 1979;29:1430.

25.

Chadwick DW , Cummings WJK , Livingstone I. , Cartlidge NEF : Acute intoxication with sodium valproate . Ann Neurol 1979;6:552-553.

26.

Blackwood W. , Buxton PH , Cummings JN , et al: Diffuse cerebral dysfunction in infancy (Alper's disease). Arch Dis Child 1963;33:193.

27.

Jellinger K. , Seitelberger F. : Spongy encephalopathies in infancy: Spongy degeneration of CNS and progressive infantile poliodystrophy, in Goldensohn ES , Appel SA (eds): Scientific Approaches to Clinical Neurology. Philadelphia , Lea & Febiger, 1977, p 363.

28.

Prick MJJ , Gabreels FJM , Trijbels JMF , et al: Progressive infantile poliodystrophy (Alper's disease) with a defect in cytochrome aa3 in muscle: A report of two unrelated patients. Clin Neurol Neurosurg 1972;85:67.

29.

Prick MJJ , Gabreels FJM , Rehier W. , et al: Pyruvate dehydrogenase deficiency restricted to brain. Neurology 1981;31: 398-404.

30.

Karpati G. , Carpenter S. , Engel AG , et al: The syndrome of systemic carnitine deficiency. Neurology 1975;25:16-24.

31.

Levitan MD , Murphy JT , Sherwood WG , et al: Adult onset systemic carnitine deficiency: Favorable response to L-carnitine supplementation. Can J Neurol Sci 1987;14:50-54.

32.

Przyrembel H. , Wendel U. , Becker K. , et al: Glutaric aciduria type II: Report on a previously undescribed metabolic disorder. Clin Chim Acta 1976;66:227-239.

33.

Tanaka K. , Mantagos S. , Genel M. , et al: New defect in fatty-acid metabolism with hypoglycemia and organic aciduria. Lancet 1977;2:986-987.

34.

Tanaka K. , Rosenberg LE : Disorders of branched chain amino acid and organic acid metabolism , in Stanbury JB (ed): The Metabolic Basis of Inherited Disease, 5th ed. New York, McGraw-Hill, 1983, p 440-473.

35.

Dusheiko G. , Kew MC , Joffe BI , et al: Recurrent hypoglycemia associated with glutaric aciduria type II in an adult. N Engl J Med 1979;301:1405-1409.

36.

Gregersen N. , Wintzensen H. , Kolvraa S. , et al: C6-C10-Dicarboxylic aciduria: Investigations of a patient with riboflavin responsive multiple acyl-CoA dehydrogenation defects. Pediatr Res 1982;16:861-868.

37.

Roe CR , Hoppel CL , Stacey TE , et al: Metabolic response to carnitine in methylmalonic aciduria. Arch Dis Child 1983;58:916-920.

38.

Roe CR , Millington DS , Maltby DA , et al: Diagnostic and therapeutic implications of medium-chain acylcarnitines in the medium-chain acyl-CoA dehydrogenase deficiency. Pediatr Res 1985;19:459-466.

39.

Chalmers RA , Stacey TE , Tracey BM , et al: L-Carnitine insufficiency in disorders of organic acid metabolism: Response to L-carnitine by patients with methylmalonic aciduria and 3-hydroxy-3-methylglutaric aciduria . J Inherited Metab Dis 1984; 7(Suppl 2):109-110.

40.

Chalmers RA , Roe CR , Stacey TE , Hoppel CL : Urinary excretion of L-carnitine and acylcarnitines by patients with disorders of organic acid metabolism: Evidence for secondary insufficiency of L-carnitine. Pediatr Res 1984;18:1325-1328.

41.

Baretz BH , Lollo CP , Tanaka K. : Metabolism in rats in vivo of RS-2-methylbutyrate and n-butyrate labeled with stable isotopes at various positions: Mechanisms of biosynthesis and degradation of ethylmalonyl semialdehyde and ethylmalonic acid. J Biol Chem 1979;254:3468-3478.

42.

Murphy JV , Marquardt KM , Shug AL : Valproic acid associated abnormalities of carnitine metabolism. Lancet 1985;1:820-821.

43.

Bohan TP , Millington DS , Roe CR , et al: Valproylcarnitine: A novel metabolite of valproic acid. Ann Neurol 1984;16:394.

44.

Moore KH , Decker BP , Schreefel FP : Hepatic hydrolysis of octanoyl-CoA and valproyl-CoA in control and valproate-fed animals. Int J Biochem 1988;20:175-178.

45.

Turnbull DM , Bone AJ , Bartlett K. , et al: The effects of valproate on intermediary metabolism in isolated rat hepatocytes and intact rats. Biochem Pharmacol 1983;32:1887-1892.

46.

Thurston JH , Carroll JE , Hauhart RE , Schiro JA : A single therapeutic dose of valproate affects liver carbohydrate, fat, adenylate, amino acid, coenzyme A, and carnitine metabolism in infant mice: Possible clinical significance . Life Sci 1985;36: 1643-1651.

47.

Triggs WJ , Bohan TP , Lin S-N. , Willmore LJ : Valproate induced coma with ketosis and carnitine insufficiency. Arch Neurol 1990;47:1131-1133.